Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care.
Our board-certified oncologists, radiation oncologists, hematologists, and pharmacists have operationalized protocols that cover all cancer diagnoses, and provide insights and analytics that health plans and providers can leverage to further innovation and improvement in cancer care.
Utilization Management, Purpose Built for Oncology
Oncology Analytics e-Prior Authorization platform, is purpose built for oncology to efficiently evaluate and approve high-quality and high-value treatments for cancer care.
Oncology Analytics, a comprehensive oncology benefits management and analytics company serving health plans, providers and patients in the United States and Puerto Rico announced today that its Board of Directors has appointed Rick Dean as Chief Executive Officer...read more
Oncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing
In response to the thousands of genetic and molecular tests being marketed, which consequently inundate health plans with reimbursement and policy coverage decisions, Oncology Analytics, Inc. has launched a clinical decision support tool for molecular and genetic...read more
Oncology Analytics Reports 99% Adherence to Evidence-Based Treatment Protocols Based on 50,000 Cases
Oncology Analytics, Inc. reports today that an analysis of a years’ worth of its chemotherapy protocol data totaling more than 50,000 approved oncology cases ending June 2017 indicates that 98.64% of approved protocols were supported by a high level of scientific...read more